SCHEMBL9059147

SCHEMBL9059147

Cc1cccc(N2CCOCC2)c1[N+](=O)[O-]

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.55
TDP1 Q9NUW8 2/20 0.55
CTSB P07858 1/20 0.51
SLC6A5 Q9Y345 1/20 0.51
MAPT P10636 5/20 0.49
KDM4E B2RXH2 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
TSHR P16473 1/20 0.49
POLB P06746 1/20 0.48
PRKDC P78527 1/20 0.48
AKR1C3 P42330 1/20 0.48
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
CYP2C9 P11712 3/20 0.47
CYP2C19 P33261 3/20 0.47
CYP1A2 P05177 2/20 0.47
CYP3A4 P08684 1/20 0.47
LMNA P02545 2/20 0.47
MAPK1 P28482 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9059478 0.90 CTSB (0.56) ALDH1A1TDP1CTSBMAPTKDM4E
SCHEMBL3084638 0.84 ALDH1A1 (0.58) ALDH1A1TDP1CTSBMAPTL3MBTL1
SCHEMBL11398153 0.84 HTT (0.54) ALDH1A1CTSBSLC6A5MAPTL3MBTL1
SCHEMBL1199786 0.83 MAPT (0.51) ALDH1A1TDP1CTSBSLC6A5MAPT
SCHEMBL28049531 0.83 CTSB (0.50) ALDH1A1TDP1CTSBMAPTKDM4E
SCHEMBL9059492 0.83 ALDH1A1 (0.52) ALDH1A1TDP1CTSBMAPTKDM4E
SCHEMBL20509867 0.83 CTSB (0.50) ALDH1A1TDP1CTSBMAPTKDM4E
SCHEMBL16054145 0.83 MAPT (0.51) ALDH1A1TDP1CTSBMAPTMEN1
SCHEMBL31022966 0.82 ALDH1A1 (0.50) ALDH1A1TDP1CTSBMAPTL3MBTL1
SCHEMBL17565226 0.81 MAPT (0.54) ALDH1A1CTSBSLC6A5MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1368883-A Method for lowering serum glucose and triglyceride levels and inhibiting angiogenesis using indolealkanoic acids INST PHARMACEUTICAL DISCOVERY (US) 2002-09-11 CN disclosed
WO-1996017612-A1 USE OF SUBSTITUTED PHENYLAMIDINE AND PHENYLGUANIDINE COMPOUNDS FOR THE TREATMENT OF CEREBRAL AND CARDIAC ISCHAEMIA, CONVULSION AND SICKLE CELL ANAEMIA KNOLL AKTIENGESELLSCHAFT (DE) 1996-06-13 WO disclosed